SHALBYNSEShalby LimitedMediumPositive
Announced Sat, 11 Apr · 18:43 IST

Shalby Limited has informed the Exchange regarding 'Receipt of approval for Kidney Transplant at Shalby Hospitals, Krishna Unit Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Regulatory Product ApprovalBusiness Updates View source PDF

SHALBY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.5%1-day move
₹153.10
prior close
₹150.67
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.2+0.2+0.4+4.5+5.1+6.1+3.1+4.5+3.5+8.8+6.8+11.0+11.9
Up moveDown movePending
AI summary

Shalby Hospitals' Krishna unit in Ahmedabad, Gujarat has received regulatory approval to perform kidney transplants for a period of 5 years, effective April 9, 2026. This approval enables the hospital to offer advanced, life-saving transplant services locally to patients in the surrounding community. The facility will provide comprehensive pre- and post-transplant management under one roof, reducing the need for patients to travel long distances for such procedures.

Likely market impact

This regulatory approval expands Shalby's medical service capabilities at the Krishna unit, potentially attracting more patients and generating incremental revenue from transplant services. It strengthens the hospital's competitive position in Gujarat's healthcare market.